These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. A comparative in vitro evaluation of six von Willebrand factor concentrates. Lethagen S, Carlson M, Hillarp A. Haemophilia; 2004 May; 10(3):243-9. PubMed ID: 15086321 [Abstract] [Full Text] [Related]
15. Plasma levels of von Willebrand factor and plasminogen activator in patients with arterial thromboembolism--with special reference to their correlation to the increased catabolism of both fibrinogen and platelets. Matsumoto M, Uchiyama T, Kobayashi N, Maekawa T. Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1105-14. PubMed ID: 2588960 [Abstract] [Full Text] [Related]
16. Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 days. Buchta C, Felfernig M, Höcker P, Macher M, Körmöczi GF, Quehenberger P, Heinzl H, Knöbl P. Vox Sang; 2004 Oct; 87(3):182-6. PubMed ID: 15569070 [Abstract] [Full Text] [Related]
17. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates. Perez-Pujol S, Tonda R, Lozano M, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G. Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989 [Abstract] [Full Text] [Related]